These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28972406)

  • 1. Brain-Derived Microparticles in Patients with Severe Isolated TBI.
    Nekludov M; Bellander BM; Gryth D; Wallen H; Mobarrez F
    Brain Inj; 2017; 31(13-14):1856-1862. PubMed ID: 28972406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
    Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
    J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study.
    Yue JK; Yuh EL; Korley FK; Winkler EA; Sun X; Puffer RC; Deng H; Choy W; Chandra A; Taylor SR; Ferguson AR; Huie JR; Rabinowitz M; Puccio AM; Mukherjee P; Vassar MJ; Wang KKW; Diaz-Arrastia R; Okonkwo DO; Jain S; Manley GT;
    Lancet Neurol; 2019 Oct; 18(10):953-961. PubMed ID: 31451409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.
    Bogoslovsky T; Wilson D; Chen Y; Hanlon D; Gill J; Jeromin A; Song L; Moore C; Gong Y; Kenney K; Diaz-Arrastia R
    J Neurotrauma; 2017 Jan; 34(1):66-73. PubMed ID: 27312416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
    Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
    Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.
    Bazarian JJ; Biberthaler P; Welch RD; Lewis LM; Barzo P; Bogner-Flatz V; Gunnar Brolinson P; Büki A; Chen JY; Christenson RH; Hack D; Huff JS; Johar S; Jordan JD; Leidel BA; Lindner T; Ludington E; Okonkwo DO; Ornato J; Peacock WF; Schmidt K; Tyndall JA; Vossough A; Jagoda AS
    Lancet Neurol; 2018 Sep; 17(9):782-789. PubMed ID: 30054151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of microparticles in the injured brain of patients with severe isolated traumatic brain injury.
    Nekludov M; Mobarrez F; Gryth D; Bellander BM; Wallen H
    J Neurotrauma; 2014 Dec; 31(23):1927-33. PubMed ID: 24956150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.
    Wang KK; Yang Z; Yue JK; Zhang Z; Winkler EA; Puccio AM; Diaz-Arrastia R; Lingsma HF; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Manley GT; Cooper SR; Dams-O'Connor K; Hricik AJ; Inoue T; Maas AI; Menon DK; Schnyer DM; Sinha TK; Vassar MJ
    J Neurotrauma; 2016 Jul; 33(13):1270-7. PubMed ID: 26560343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leakage of astrocyte-derived extracellular vesicles in stress-induced exhaustion disorder: a cross-sectional study.
    Wallensten J; Nager A; Åsberg M; Borg K; Beser A; Wilczek A; Mobarrez F
    Sci Rep; 2021 Jan; 11(1):2009. PubMed ID: 33479350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Evaluation of Aquaporin-4 and its Correlation with CD68, IBA-1, HIF-1α, GFAP, and CD15 Expressions in Fatal Traumatic Brain Injury.
    Neri M; Frati A; Turillazzi E; Cantatore S; Cipolloni L; Di Paolo M; Frati P; La Russa R; Maiese A; Scopetti M; Santurro A; Sessa F; Zamparese R; Fineschi V
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.
    Stein DM; Lindell AL; Murdock KR; Kufera JA; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
    J Neurotrauma; 2012 Apr; 29(6):1140-9. PubMed ID: 22360297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple indicators model of long-term mortality in traumatic brain injury.
    Gradisek P; Osredkar J; Korsic M; Kremzar B
    Brain Inj; 2012; 26(12):1472-81. PubMed ID: 22721420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
    Ahadi R; Khodagholi F; Daneshi A; Vafaei A; Mafi AA; Jorjani M
    Spine (Phila Pa 1976); 2015 Jul; 40(14):E823-30. PubMed ID: 25341992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial fibrillary acidic protein is highly correlated with brain injury.
    Lumpkins KM; Bochicchio GV; Keledjian K; Simard JM; McCunn M; Scalea T
    J Trauma; 2008 Oct; 65(4):778-82; discussion 782-4. PubMed ID: 18849790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
    Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A
    Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury.
    Mokhtari M; Nayeb-Aghaei H; Kouchek M; Miri MM; Goharani R; Amoozandeh A; Akhavan Salamat S; Sistanizad M
    J Clin Pharmacol; 2018 Jan; 58(1):42-47. PubMed ID: 28724200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot trial of l-carnitine in patients with traumatic brain injury: Effects on biomarkers of injury.
    Mahmoodpoor A; Shokouhi G; Hamishehkar H; Soleimanpour H; Sanaie S; Porhomayon J; Rasouli F; Nader ND
    J Crit Care; 2018 Jun; 45():128-132. PubMed ID: 29454227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.
    Vos PE; van Gils M; Beems T; Zimmerman C; Verbeek MM
    Eur J Neurol; 2006 Jun; 13(6):632-8. PubMed ID: 16796588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Concentrations of Neuron-Specific Enolase in Dogs Following Traumatic Brain Injury.
    Chai O; Mazaki-Tovi M; Klainbart S; Kelmer E; Shipov A; Shamir MH
    J Comp Pathol; 2020 Aug; 179():45-51. PubMed ID: 32958147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.